FDA Clearance Tracker · K241177
React 71 Catheter
Last checked: Nov 20, 2026Latest source record: May 28, 2024 (this decision)Source: openFDAMethods & limitations
Decided
May 28, 2024
Substantially Equivalent
Time to decision
29 days
Received Apr 29, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K241177
- Device name
- React 71 Catheter
- Applicant location
- Irvine, CA
- Received
- Apr 29, 2024
- Decided
- May 28, 2024
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Catheter, Percutaneous (DQY)
- Device class
- Class II
- Regulation
- 21 CFR 870.1250
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DQY. The earliest in FDA's data is K790083, decided Jan 25, 1979.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K241177
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Micro Therapeutics Lnc. D/B/A Ev3 Neurovascular
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K233420 · Decided Nov 7, 2023 · 28 days after receipt
Device type: Device, Neurovascular Embolization (HCG) · Neurology & Neurosurgery
- Phenom Catheters510(k)
K210230 · Decided Feb 25, 2021 · 28 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.